Pharmaceutical nanotechnology Journal

publication venue for

Recent Advancements of Stimuli-Responsive Targeted Liposomal Formulations for Cancer Drug Delivery. 2022

Electronic International Standard Serial Number (EISSN)

2211-7393

journal abbreviation

Pharm Nanotechnol